title: ESGAB breakpoint determination: temafloxacin.
authors.forename: I
authors.initials: I
authors.lastname: Phillips
authors.forename: J
authors.initials: J
authors.lastname: Acar
authors.forename: F
authors.initials: F
authors.lastname: Baquero
authors.forename: T
authors.initials: T
authors.lastname: Bergan
authors.forename: A
authors.initials: A
authors.lastname: Forsgren
authors.forename: B
authors.initials: B
authors.lastname: Wiedemann
mesh_terms: D000890:Anti-Infective Agents / Q000008:administration & dosage / Q000493:pharmacokinetics / Q000494:pharmacology*; D001419:Bacteria / Q000187:drug effects*; D001424:Bacterial Infections / Q000188:drug therapy; D024841:Fluoroquinolones; D006801:Humans; D008826:Microbial Sensitivity Tests; D015363:Quinolones / Q000008:administration & dosage / Q000493:pharmacokinetics / Q000494:pharmacology*
chemical_list: D000890:Anti-Infective Agents; D024841:Fluoroquinolones; D015363:Quinolones; C054745:temafloxacin